Company Filing History:
Years Active: 2014
Title: Ikeda Kazuhiro: Innovator in Cancer Treatment
Introduction
Ikeda Kazuhiro is a notable inventor based in Iruma-gun, Japan. He has made significant contributions to the field of cancer research through his innovative work in nucleic acid molecules. His research focuses on developing pharmaceutical agents that can effectively prevent or treat cancer.
Latest Patents
Ikeda holds a patent for a double-stranded nucleic acid molecule that acts as a cancer cell proliferation inhibitor. This invention includes a sense strand with a nucleotide sequence corresponding to a target sequence and an antisense strand that is complementary to the sense strand. The double-stranded nucleic acid molecule is designed to suppress the expression of at least one of the APP and EBAG9 genes, showcasing its potential in cancer therapy. He has 1 patent to his name.
Career Highlights
Throughout his career, Ikeda has worked with esteemed institutions such as Saitama Medical University and Rnai Co., Ltd. His research has contributed to advancements in understanding cancer mechanisms and developing targeted therapies.
Collaborations
Ikeda has collaborated with various professionals in his field, including his coworker Satoshi Inoue, who has also contributed to cancer research.
Conclusion
Ikeda Kazuhiro's innovative work in the development of nucleic acid molecules represents a significant advancement in cancer treatment. His contributions continue to inspire further research and development in this critical area of medicine.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.